Regenera Pharma Ltd
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) (NCT03547206) | Regenera Pharma Ltd | 2018-07-10 |
| A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease (NCT03462121) | Regenera Pharma Ltd | 2018-03-01 |
| Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION). (NCT02045212) | Regenera Pharma Ltd | 2014-02-01 |
| A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease (NCT01513967) | Regenera Pharma Ltd | 2012-01-01 |
| Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn (NCT01455480) | Regenera Pharma Ltd | 2011-12-01 |
| Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds (NCT01429519) | Regenera Pharma Ltd | 2011-12-01 |
Track Regenera Pharma Ltd automatically
Every clearance here is in the API, with alerts when new ones post.